SS Innovations International SSII
NASDAQ SSII
$3.65 +0.05 (+1.39%)
At close: Aug 20, 2026 · 2:28 PM UTC

SS Innovations International (SSII) Income from Non-Controlling Interests (2022 - 2023)

SS Innovations International (SSII) posted Income from Non-Controlling Interests of -$1.9 million for Q3 2023, down 76.68% sequentially from -$1.1 million in Q2 2023, and down 725.1% YoY from $303717.0 in Q3 2022.

SS Innovations International (SSII) Income from Non-Controlling Interests (2022 - 2023) Analysis & Trends

SS Innovations International has reported Income from Non-Controlling Interests for 2 years, with the latest figure at -$1.9 million in Q3 2023.

  • Quarterly Income from Non-Controlling Interests fell 725.1% year-over-year to -$1.9 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was -$3.3 million (changed N/A YoY) and the FY2021 annual result came in at -$352.0, changed N/A from the prior year.
  • Income from Non-Controlling Interests retreated to -$1.9 million in Q3 2023 per SSII's latest filing, from -$1.1 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $303717.0 in Q3 2022 and troughed at -$1.9 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn -
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn -
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn -2.00 Mn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn -500,000.00
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 13.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 2.32 Mn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn 900,000.00
10 SS Innovations International 730.50 Mn 708.20 Mn 7.10 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 -1.90 Mn
Jun 30, 2023 -1.07 Mn
Sep 30, 2022 303,717.00
Jun 30, 2022 -582,023.00